These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3980085)

  • 1. Simultaneous loss of bacteriophage receptor and coaggregation mediator activities in Actinomyces viscosus MG-1.
    Tylenda CA; Enriquez E; Kolenbrander PE; Delisle AL
    Infect Immun; 1985 Apr; 48(1):228-33. PubMed ID: 3980085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bacteriophage-resistant mutants to study Actinomyces viscosus cell surface receptors.
    Tylenda CA; Kolenbrander PE; Delisle AL
    J Dent Res; 1983 Nov; 62(11):1179-81. PubMed ID: 6580320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.
    Cisar JO; Kolenbrander PE; McIntire FC
    Infect Immun; 1979 Jun; 24(3):742-52. PubMed ID: 468376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.
    Kolenbrander PE
    Infect Immun; 1982 Sep; 37(3):1200-8. PubMed ID: 7129635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis.
    Kolenbrander PE; Williams BL
    Infect Immun; 1981 Jul; 33(1):95-102. PubMed ID: 7263074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Actinomyces and Streptococcus coaggregation groups among human oral isolates from the same site.
    Kolenbrander PE; Inouye Y; Holdeman LV
    Infect Immun; 1983 Aug; 41(2):501-6. PubMed ID: 6409807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Actinomyces bacteriophage from human dental plaque.
    Tylenda CA; Calvert C; Kolenbrander PE; Tylenda A
    Infect Immun; 1985 Jul; 49(1):1-6. PubMed ID: 4008044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of saliva on coaggregation of oral Actinomyces and Streptococcus species.
    Kolenbrander PE; Phucas CS
    Infect Immun; 1984 May; 44(2):228-33. PubMed ID: 6370861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interbacterial adherence between Actinomyces viscosus and strains of Streptococcus pyogenes, Streptococcus agalactiae, and Pseudomonas aeruginosa.
    Komiyama K; Gibbons RJ
    Infect Immun; 1984 Apr; 44(1):86-90. PubMed ID: 6423545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular coaggregation of oral Streptococcus milleri with actinomyces.
    Eifuku H; Yakushiji T; Mizuno J; Kudo N; Inoue M
    Infect Immun; 1990 Jan; 58(1):163-8. PubMed ID: 2294047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 95 kDa putative adhesin from Actinomyces serovar WVA963 strain PK1259 that is distinct from type 2 fimbrial subunits.
    Klier CM; Kolenbrander PE; Roble AG; Marco ML; Cross S; Handley PS
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():835-846. PubMed ID: 9084167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of viridans streptococci exhibiting lactose-inhibitable coaggregation with oral actinomycetes.
    Kolenbrander PE; Williams BL
    Infect Immun; 1983 Aug; 41(2):449-52. PubMed ID: 6409806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of coaggregation-defective (Cog-) mutants of Streptococcus gordonii DL1 (Challis).
    Clemans DL; Kolenbrander PE
    J Ind Microbiol; 1995 Sep; 15(3):193-7. PubMed ID: 8519477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of independent Streptococcus gordonii SspA and SspB functions in coaggregation with Actinomyces naeslundii.
    Egland PG; Dû LD; Kolenbrander PE
    Infect Immun; 2001 Dec; 69(12):7512-6. PubMed ID: 11705927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque.
    Palmer RJ; Gordon SM; Cisar JO; Kolenbrander PE
    J Bacteriol; 2003 Jun; 185(11):3400-9. PubMed ID: 12754239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of lactose-reversible coadhesion of Actinomyces naeslundii WVU 398A and Streptococcus oralis 34 on the surface of hexadecane droplets.
    Ellen RP; Veisman H; Buivids IA; Rosenberg M
    Oral Microbiol Immunol; 1994 Dec; 9(6):364-71. PubMed ID: 7870472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coaggregation of oral Bacteroides species with other bacteria: central role in coaggregation bridges and competitions.
    Kolenbrander PE; Andersen RN; Holdeman LV
    Infect Immun; 1985 Jun; 48(3):741-6. PubMed ID: 3888842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.